Italia

8 nuovi farmaci in commercio

Nuove specialitÓ medicinali: Annova, Clautero, Exelon, Ezevast, Cosentyx.

Nuove specialità medicinali
ANNOVA 30 cpr riv 1.000 Unita' Internazionali colecalciferolo
IBN SAVIO AIC: 046282024 6,90€ Cnn/RR in commercio dal: 15/12/2021

CLAUTERO 12 cpr riv 875 mg + 125 mg amoxicillina triidrato/potassio clavulanato
SANDOZ AIC: 042174045 7,90€ A /RR in commercio dal: 29/11/2021

EXELON 30 cerotti transd 4,6 mg/die rivastigmina
NOVARTIS AIC: 034078360 102,78€ A /RRL in commercio dal: 26/11/2021

EZEVAST 30 cpr riv 10 mg + 10 mg ezetimibe/atorvastatina calcio triidrato
FIDIA AIC: 048444020 10,30€ A /RR in commercio dal: 15/12/2021

EZEVAST 30 cpr riv 10 mg + 20 mg ezetimibe/atorvastatina calcio triidrato
FIDIA AIC: 048444069 11,83€ A /RR in commercio dal: 15/12/2021

EZEVAST 30 cpr riv 10 mg + 40 mg ezetimibe/atorvastatina calcio triidrato
FIDIA AIC: 048444107 12,50€ A /RR in commercio dal: 15/12/2021

EZEVAST 30 cpr riv 10 mg + 80 mg ezetimibe/atorvastatina calcio triidrato
FIDIA AIC: 048444145 13,97€ A /RR in commercio dal: 15/12/2021

COSENTYX 1 siringa preriempita SC 300 mg 2 ml 150 mg/ml secukinumab
NOVARTIS AIC: 043873088 1.563,96€ H /RRL in commercio dal: 15/12/2021